Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
Active, not recruiting · NCT01644669 · Registry updated 2025-01-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® | Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, breast carcinoma in situ, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, invasive ductal breast carcinoma, neoplasm | Active, not recruiting | Not applicable | 2025-01-31 | NCT01644669 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Icad, Inc. | 1 |
| Xoft, Inc. | 1 |
24 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.